E. Ohman J:or Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

E. Ohman J:or Asset Management’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88M	Buy	45,794 +3,707	+9%	+$237K	0.07%	148
2026 Q1	$2.95M	Buy	42,087 +8,764	+26%	+$612K	0.08%	134
2025 Q4	$2.73M	Sell	33,323 -5,000	-13%	-$373K	0.06%	144
2025 Q3	$2.28M	Sell	38,323 -2,700	-7%	-$133K	0.05%	170
2025 Q2	$1.66M	Sell	41,023 -1,958	-5%	-$88.1K	0.04%	202
2025 Q1	$2.21M	Buy	42,981 +8,200	+24%	+$405K	0.06%	163
2024 Q4	$1.93M	Sell	34,781 -12,200	-26%	-$554K	0.04%	178
2024 Q3	$1.55M	Buy	46,981 +8,000	+21%	+$225K	0.04%	196
2024 Q2	$1.06M	Buy	38,981 +13,981	+56%	+$470K	0.03%	245
2024 Q1	$909K	Buy	+25,000	New	+$735K	0.02%	265

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

E. Ohman J:or Asset Management's TARS Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Tarsus Pharmaceuticals (TARS) stake by 8.8% in Q2 2026, buying an estimated $237K and bringing the position to 45,794 shares worth $2.88M. The position accounts for 0.07% of the portfolio, ranked #148.

E. Ohman J:or Asset Management first reported a position in TARS in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.95M in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

E. Ohman J:or Asset Management held 45,794 shares of Tarsus Pharmaceuticals worth $2.88M as of Q2 2026.
E. Ohman J:or Asset Management bought 3,707 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $237K.
Tarsus Pharmaceuticals made up 0.07% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #148 holding.
E. Ohman J:or Asset Management first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
E. Ohman J:or Asset Management's Tarsus Pharmaceuticals position peaked at $2.95M in Q1 2026.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.